Search Results

Astellas Pharma US, Inc. (“Astellas”) announced today the company has entered into a sponsored research agreement with the UMass Chan Medical School to proceed with research for an adeno-associated virus (AAV) vector mediated gene therapy for the treatment of Alexander disease, a fatal, ultra-rare disease for which the only current treatment option is supportive care.

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced it has received regulatory approval from the Maryland Cannabis Administration (MCA) for the acquisition previously announced on June 8, 2023, of Derby 1, LLC (d/b/a “Peninsula Alternative Health”), a medical dispensary in Maryland.

Healis Therapeutics is pleased to announce that it has entered a clinical collaboration with Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health system, and affiliates of Harvard Medical School (HMS).

After significant expansion within the U.S. Inspired Spine is taking it’s Minimally Invasive life-altering surgical approach and technology to the Arabian Peninsula.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Phase 2 PENINSULA trial evaluating VIR-2482 for the prevention of symptomatic influenza A illness did not meet primary or secondary efficacy endpoints.